L. Morrison

发表

Novel Approach to the Formulation of an Epstein-Barr Virus Antigen-Based Nasopharyngeal Carcinoma Vaccine

D. Moss, S. Thomson, P. Crooks, 2009, Journal of Virology.

Melphalan‐induced chromosome damage in sensitive and resistant human melanoma cell lines

P. Parsons, L. Morrison, 1978, International journal of cancer.

Expansion of EBNA1-specific effector T cells in posttransplantation lymphoproliferative disorders.

S. Burrows, D. Moss, M. Gandhi, 2010, Blood.

Asymptomatic primary Epstein-Barr virus infection occurs in the absence of blood T-cell repertoire perturbations despite high levels of systemic viral load.

S. L. Silins, R. Khanna, D. Moss, 2001, Blood.

Optimization of LMP‐specific CTL expansion for potential adoptive immunotherapy in NPC patients

D. Tscharke, D. Moss, Mark C. Smith, 2009, Immunology and cell biology.

blood T-cell repertoire perturbations despite high levels of systemic viral load Asymptomatic primary Epstein-Barr virus infection occurs in the absence of

S. L. Silins, R. Khanna, D. Moss, 2013 .

Use of CD107‐based cell sorting ex vivo to enrich subdominant CD8+ T cells in culture

D. Tscharke, D. Moss, L. Morrison, 2007, Immunology and cell biology.

Reconstitution of the latent T-lymphocyte response to Epstein-Barr virus is coincident with long-term recovery from posttransplant lymphoma after adoptive immunotherapy

Richard E. Slaughter, J. Burrows, R. Khanna, 2003, Transplantation.

Cytotoxic T Cell Adoptive Immunotherapy as a Treatment for Nasopharyngeal Carcinoma

D. Moss, B. Panizza, P. Crooks, 2013, Clinical and Vaccine Immunology.

Determining virological, serological and immunological parameters of EBV infection in the development of PTLD.

R. Khanna, T. Kotsimbos, D. Moss, 2004, International immunology.